Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells

Russell D'Ambra, Manju Surana, Shimon Efrat, Robert G. Starr, Norman Fleischer

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Insulin secretory physiology has been characterized in tumor cell lines derived by primary culture of insulinomas that developed in transgenic mice expressing the large T-antigen of SV40 in pancreatic islet β-cells. Cells in one of these lines, βTC-3, contain large amounts of insulin (3100 ± 294 ng/100 μg cellular protein). Constitutive release of insulin over 2 h in static incubation was low at 31.9 ng/100 μg protein and was increased 2-fold by glucose (16.7 mM) and 8-fold by depolarizing concentrations of potassium (45 mM). Isobutylmethylxanthine (IBMX; 0.5 mM) and forskolin (5 and 50 μM), which elevated cellular levels of cAMP, were ineffective as secretagogues, but dramatically potentiated glucose and potassium effects on insulin release (6.5- and 4-fold, respectively). A variety of other known insulin secretagogues stimulated insulin release in a manner analogous to their effects in normal islets. The sulfonylurea glipizide (1 μM) and the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (1 μM) stimulated insulin release 3.4-and 13.7-fold, respectively. The cholinergic agonist carbachol (2 μM) was ineffective alone, but potentiated glucose-induced insulin release 2.8-fold. Comparable stimulation of insulin release by glucose (16.7 mM) and glucose (16.7 mM) plus IBMX (0.5 mM) was noted with several other βTC lines, which were derived independently from separate transgenic mice. Glucose- and glucose- plus IBMX (0.5 mM)-induced insulin release occurred progressively from 0.15-16.7 mM, indicating that insulin release from βTC-3 cells occurred at much lower levels than that from normal islets. However, as in the normal islet, the glucose concentration dependency for insulin release was highly correlated (r = 0.93) with the glucose concentration dependency for glucose utilization (measured by 3H2O formation from [5-3H]glucose). This suggests that glucose induces insulin release from βTC-3 cells by a mechanism similar to that in the normal islet. The high insulin content, the multifold stimulation of insulin release by a variety of secretagogues, their convenient propagation in culture, and the renewable source of these cell lines make the βTC cells a convenient model for studies of β-cell function.

Original languageEnglish (US)
Pages (from-to)2815-2822
Number of pages8
JournalEndocrinology
Volume126
Issue number6
StatePublished - Jun 1990

Fingerprint

Insulinoma
Transgenic Mice
Insulin
Cell Line
Glucose
1-Methyl-3-isobutylxanthine
Islets of Langerhans
Potassium
Glipizide
Cholinergic Agonists
Viral Tumor Antigens
Carbachol
Phorbol Esters
Tetradecanoylphorbol Acetate
Colforsin
Tumor Cell Line

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

D'Ambra, R., Surana, M., Efrat, S., Starr, R. G., & Fleischer, N. (1990). Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells. Endocrinology, 126(6), 2815-2822.

Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells. / D'Ambra, Russell; Surana, Manju; Efrat, Shimon; Starr, Robert G.; Fleischer, Norman.

In: Endocrinology, Vol. 126, No. 6, 06.1990, p. 2815-2822.

Research output: Contribution to journalArticle

D'Ambra, R, Surana, M, Efrat, S, Starr, RG & Fleischer, N 1990, 'Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells', Endocrinology, vol. 126, no. 6, pp. 2815-2822.
D'Ambra, Russell ; Surana, Manju ; Efrat, Shimon ; Starr, Robert G. ; Fleischer, Norman. / Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells. In: Endocrinology. 1990 ; Vol. 126, No. 6. pp. 2815-2822.
@article{679cf5c92613499cb119398137c3cfdc,
title = "Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells",
abstract = "Insulin secretory physiology has been characterized in tumor cell lines derived by primary culture of insulinomas that developed in transgenic mice expressing the large T-antigen of SV40 in pancreatic islet β-cells. Cells in one of these lines, βTC-3, contain large amounts of insulin (3100 ± 294 ng/100 μg cellular protein). Constitutive release of insulin over 2 h in static incubation was low at 31.9 ng/100 μg protein and was increased 2-fold by glucose (16.7 mM) and 8-fold by depolarizing concentrations of potassium (45 mM). Isobutylmethylxanthine (IBMX; 0.5 mM) and forskolin (5 and 50 μM), which elevated cellular levels of cAMP, were ineffective as secretagogues, but dramatically potentiated glucose and potassium effects on insulin release (6.5- and 4-fold, respectively). A variety of other known insulin secretagogues stimulated insulin release in a manner analogous to their effects in normal islets. The sulfonylurea glipizide (1 μM) and the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (1 μM) stimulated insulin release 3.4-and 13.7-fold, respectively. The cholinergic agonist carbachol (2 μM) was ineffective alone, but potentiated glucose-induced insulin release 2.8-fold. Comparable stimulation of insulin release by glucose (16.7 mM) and glucose (16.7 mM) plus IBMX (0.5 mM) was noted with several other βTC lines, which were derived independently from separate transgenic mice. Glucose- and glucose- plus IBMX (0.5 mM)-induced insulin release occurred progressively from 0.15-16.7 mM, indicating that insulin release from βTC-3 cells occurred at much lower levels than that from normal islets. However, as in the normal islet, the glucose concentration dependency for insulin release was highly correlated (r = 0.93) with the glucose concentration dependency for glucose utilization (measured by 3H2O formation from [5-3H]glucose). This suggests that glucose induces insulin release from βTC-3 cells by a mechanism similar to that in the normal islet. The high insulin content, the multifold stimulation of insulin release by a variety of secretagogues, their convenient propagation in culture, and the renewable source of these cell lines make the βTC cells a convenient model for studies of β-cell function.",
author = "Russell D'Ambra and Manju Surana and Shimon Efrat and Starr, {Robert G.} and Norman Fleischer",
year = "1990",
month = "6",
language = "English (US)",
volume = "126",
pages = "2815--2822",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Regulation of insulin secretion from β-cell lines derived from transgenic mice insulinomas resembles that of normal β-cells

AU - D'Ambra, Russell

AU - Surana, Manju

AU - Efrat, Shimon

AU - Starr, Robert G.

AU - Fleischer, Norman

PY - 1990/6

Y1 - 1990/6

N2 - Insulin secretory physiology has been characterized in tumor cell lines derived by primary culture of insulinomas that developed in transgenic mice expressing the large T-antigen of SV40 in pancreatic islet β-cells. Cells in one of these lines, βTC-3, contain large amounts of insulin (3100 ± 294 ng/100 μg cellular protein). Constitutive release of insulin over 2 h in static incubation was low at 31.9 ng/100 μg protein and was increased 2-fold by glucose (16.7 mM) and 8-fold by depolarizing concentrations of potassium (45 mM). Isobutylmethylxanthine (IBMX; 0.5 mM) and forskolin (5 and 50 μM), which elevated cellular levels of cAMP, were ineffective as secretagogues, but dramatically potentiated glucose and potassium effects on insulin release (6.5- and 4-fold, respectively). A variety of other known insulin secretagogues stimulated insulin release in a manner analogous to their effects in normal islets. The sulfonylurea glipizide (1 μM) and the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (1 μM) stimulated insulin release 3.4-and 13.7-fold, respectively. The cholinergic agonist carbachol (2 μM) was ineffective alone, but potentiated glucose-induced insulin release 2.8-fold. Comparable stimulation of insulin release by glucose (16.7 mM) and glucose (16.7 mM) plus IBMX (0.5 mM) was noted with several other βTC lines, which were derived independently from separate transgenic mice. Glucose- and glucose- plus IBMX (0.5 mM)-induced insulin release occurred progressively from 0.15-16.7 mM, indicating that insulin release from βTC-3 cells occurred at much lower levels than that from normal islets. However, as in the normal islet, the glucose concentration dependency for insulin release was highly correlated (r = 0.93) with the glucose concentration dependency for glucose utilization (measured by 3H2O formation from [5-3H]glucose). This suggests that glucose induces insulin release from βTC-3 cells by a mechanism similar to that in the normal islet. The high insulin content, the multifold stimulation of insulin release by a variety of secretagogues, their convenient propagation in culture, and the renewable source of these cell lines make the βTC cells a convenient model for studies of β-cell function.

AB - Insulin secretory physiology has been characterized in tumor cell lines derived by primary culture of insulinomas that developed in transgenic mice expressing the large T-antigen of SV40 in pancreatic islet β-cells. Cells in one of these lines, βTC-3, contain large amounts of insulin (3100 ± 294 ng/100 μg cellular protein). Constitutive release of insulin over 2 h in static incubation was low at 31.9 ng/100 μg protein and was increased 2-fold by glucose (16.7 mM) and 8-fold by depolarizing concentrations of potassium (45 mM). Isobutylmethylxanthine (IBMX; 0.5 mM) and forskolin (5 and 50 μM), which elevated cellular levels of cAMP, were ineffective as secretagogues, but dramatically potentiated glucose and potassium effects on insulin release (6.5- and 4-fold, respectively). A variety of other known insulin secretagogues stimulated insulin release in a manner analogous to their effects in normal islets. The sulfonylurea glipizide (1 μM) and the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (1 μM) stimulated insulin release 3.4-and 13.7-fold, respectively. The cholinergic agonist carbachol (2 μM) was ineffective alone, but potentiated glucose-induced insulin release 2.8-fold. Comparable stimulation of insulin release by glucose (16.7 mM) and glucose (16.7 mM) plus IBMX (0.5 mM) was noted with several other βTC lines, which were derived independently from separate transgenic mice. Glucose- and glucose- plus IBMX (0.5 mM)-induced insulin release occurred progressively from 0.15-16.7 mM, indicating that insulin release from βTC-3 cells occurred at much lower levels than that from normal islets. However, as in the normal islet, the glucose concentration dependency for insulin release was highly correlated (r = 0.93) with the glucose concentration dependency for glucose utilization (measured by 3H2O formation from [5-3H]glucose). This suggests that glucose induces insulin release from βTC-3 cells by a mechanism similar to that in the normal islet. The high insulin content, the multifold stimulation of insulin release by a variety of secretagogues, their convenient propagation in culture, and the renewable source of these cell lines make the βTC cells a convenient model for studies of β-cell function.

UR - http://www.scopus.com/inward/record.url?scp=0025374590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025374590&partnerID=8YFLogxK

M3 - Article

C2 - 1693563

AN - SCOPUS:0025374590

VL - 126

SP - 2815

EP - 2822

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -